Pathology labs were already struggling with diagnostics backlogs. Then COVID-19 hit.
In this whitepaper, we explore how lab automation can help teams to scale testing for COVID-19 – and get them better prepared for future health crises.
“The Covid-19 pandemic has exacerbated the pre-existing problems in Diagnostics”
Will lab automation relieve the pressure on diagnostics teams?
Conducting testing at the scale needed to tackle the COVID-19 pandemic has meant that thousands of (highly-trained) lab workers are conducting exhausting, repetitive tasks over and over again. But when COVID-19 testing is handled manually, it not only exhausts workers, it also means that testing targets are missed, human error is common and staff’s safety is not ensured.
Lab automation removes these problems, tripling the output of test and trace facilities and ensuring social distancing is possible for key workers.
For a lab automation solution to be effective, it needs to:
🤖 Accelerate the output
🤖. Be rapidly deployed
🤖. Be flexible and easily integrated with existing equipment
At Automata, we worked with one national test and trace facility facility to create a lab automation solution that could automate the process of reformatting COVID-19 samples.
With the Autosampler solution, we were able to clinically validate and scale testing from 1,000 a day with manual testing, to 100,000 a day with automation within the same facility.
Get the whitepaper to learn the key requirements for pathology leaders to run simple, hassle-free automation on-site – and how one test and trace facility was empowered to scale their COVID-19 testing with automation on-site in a matter of weeks.